Immunocore Holdings plc - ADR (IMCR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / ADR
Symbol
IMCR on Nasdaq
Shares outstanding
50,518,873
Price per share
$33.33
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
51,534,390
Total reported value
$1,787,265,456
% of total 13F portfolios
0%
Share change
+1,780,354
Value change
+$61,520,296
Number of holders
147
Price from insider filings
$33.33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Immunocore Holdings plc - ADR (IMCR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 12% -16% $192,547,632 -$35,226,089 5,961,227 -15% T. Rowe Price Investment Management, Inc. 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP 10% +12% $177,495,613 +$21,348,793 5,132,898 +14% Wellington Management Group LLP 31 Jul 2025
Jallal Bahija 8.2% $135,513,072 4,493,139 Jallal Bahija 31 Dec 2024
PRIMECAP MANAGEMENT CO/CA/ 7.5% +44% $130,443,852 +$38,165,393 3,772,234 +41% PRIMECAP MANAGEMENT CO/CA/ 30 Jun 2025
Bellevue Group AG 5.6% $101,607,853 2,796,803 Bellevue Group AG 20 Aug 2025
TANG CAPITAL MANAGEMENT LLC 5.2% $94,662,520 2,605,608 TANG CAPITAL MANAGEMENT, LLC 17 Oct 2025

As of 31 Dec 2025, 147 institutional investors reported holding 51,534,390 shares of Immunocore Holdings plc - ADR (IMCR). This represents 102% of the company’s total 50,518,873 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Immunocore Holdings plc - ADR (IMCR) together control 90% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
T. Rowe Price Investment Management, Inc. 12% 5,961,227 -16% 0.13% $206,915,000
RTW INVESTMENTS, LP 9.6% 4,869,798 0% 1.7% $169,030,689
WELLINGTON MANAGEMENT GROUP LLP 9.3% 4,693,643 -1.8% 0.03% $162,916,349
FMR LLC 9% 4,539,225 +2.7% 0.01% $157,556,482
PRIMECAP MANAGEMENT CO/CA/ 7.8% 3,961,880 +5.5% 0.1% $137,516,856
Bellevue Group AG 5.5% 2,796,803 0% 1.8% $97,077,032
TANG CAPITAL MANAGEMENT LLC 5.2% 2,628,538 +14% 4.5% $91,236,554
BAKER BROS. ADVISORS LP 4.6% 2,322,656 0% 0.47% $80,619,390
Deep Track Capital, LP 4% 2,003,978 +11% 1.6% $69,558,076
BVF INC/IL 2.9% 1,488,975 -5.4% 1.7% $50,293,922
ARMISTICE CAPITAL, LLC 2.2% 1,098,000 +33% 0.93% $38,111,580
Fiera Capital Corp 2.1% 1,044,831 +31% 0.12% $36,266,084
PRICE T ROWE ASSOCIATES INC /MD/ 1.9% 968,784 -4.7% 0% $33,627,000
MILLENNIUM MANAGEMENT LLC 1.8% 911,597 -28% 0.02% $31,641,532
Kynam Capital Management, LP 1.7% 856,462 -15% 1.9% $29,727,796
Logos Global Management LP 1.7% 850,000 0% 2% $29,503,500
Trails Edge Capital Partners, LP 1.4% 682,597 0% 5.9% $23,692,942
PRINCIPAL FINANCIAL GROUP INC 1.3% 658,436 +60% 0.01% $22,854,314
Vestal Point Capital, LP 1.2% 585,000 0.74% $20,305,350
Point72 Asset Management, L.P. 1% 504,151 -5.9% 0.03% $17,499,081
ACADIAN ASSET MANAGEMENT LLC 0.91% 461,830 +131% 0.03% $16,012,000
JANUS HENDERSON GROUP PLC 0.9% 454,404 0.01% $15,733,739
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.81% 407,404 -7.9% 0% $14,140,993
Frazier Life Sciences Management, L.P. 0.76% 384,782 0% 0.36% $13,355,783
Hudson Bay Capital Management LP 0.76% 383,558 +15% 0.08% $13,313,298

Institutional Holders of Immunocore Holdings plc - ADR (IMCR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 51,534,390 $1,787,265,456 +$61,520,296 $34.71 147
2025 Q3 49,181,489 $1,786,701,511 +$50,897,730 $36.33 132
2025 Q2 47,759,431 $1,498,675,257 +$17,984,702 $31.38 132
2025 Q1 47,287,653 $1,402,998,400 +$60,274,148 $29.67 115
2024 Q4 45,410,647 $1,339,563,608 -$4,915,367 $29.50 114
2024 Q3 45,295,985 $1,411,075,539 +$61,107,953 $31.13 129
2024 Q2 43,068,701 $1,459,854,294 -$99,787,937 $33.89 135
2024 Q1 41,233,666 $2,679,814,816 +$238,809,048 $65.00 149
2023 Q4 37,514,062 $2,563,043,022 +$32,940,976 $68.32 133
2023 Q3 36,945,020 $1,917,423,501 +$85,494,203 $51.90 125
2023 Q2 35,306,138 $2,115,733,529 +$164,020,008 $59.96 118
2023 Q1 32,689,414 $1,614,615,481 +$118,700,415 $49.44 108
2022 Q4 30,264,419 $1,727,211,273 +$217,928,825 $57.07 103
2022 Q3 26,369,515 $1,237,624,033 +$261,557,875 $46.94 83
2022 Q2 21,039,614 $784,510,369 +$56,584,747 $37.31 66
2022 Q1 19,740,280 $590,138,252 +$57,754,634 $29.90 57
2021 Q4 17,133,052 $586,618,000 +$22,048,655 $34.24 45
2021 Q3 16,654,128 $617,381,000 +$83,084,443 $37.07 46
2021 Q2 13,805,464 $538,109,000 +$10,183,214 $39.05 41
2021 Q1 14,110,965 $597,836,000 +$597,835,003 $42.57 41